Prostate cancer, Secondary cancers
Open
Phase 3
This trial is looking at adding certain treatments to hormone treatment for prostate cancer that has spread to other parts of the body.
Cancer Research UK supports this trial.
Recruitment start: 1 June 2024
Recruitment end: 1 January 2030
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nick James Professor Gert Attard
University College London
Medical Research Council (MRC) Clinical Trials Unit at UCL
Cancer Research UK
Medical Research Council
Advanced Accelerator Applications (ADACAP) Novartis
Johnson & Johnson (provided funding during trial setup period)
There is more information about the trial on the STAMPEDE2 trial website(link is external).
Last reviewed: 14 Mar 2025
CRUK internal database number: 19502